Filing metadata

Accession number
0000950170-24-066648
Form type
Form 3
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
May 30, 2024
Reporting period
May 30, 2024
Description
Initial ownership

Explore SEC Filings Hub